Therapeutic Solutions International, Inc. engages in the provision of immune modulation for the treatment of several specific diseases. The firm is also involved in developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, traumatic brain injury, and for daily health. The company was founded on August 6, 2007 and is headquartered in Elk, ID.